[HTML][HTML] Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
N Chavarot, A Morel, M Leruez-Ville, E Vilain… - American Journal of …, 2021 - Elsevier
Poor responses to mRNA COVID-19 vaccine have been reported after 2 vaccine injections
in kidney transplant recipients (KTRs) treated with belatacept. We analyzed the humoral
response in belatacept-treated KTRs without a history of SARS-CoV-2 infection who
received three injections of BNT162b2-mRNA COVID-19 vaccine. We also investigated
vaccine immunogenicity in belatacept-treated KTRs with prior COVID-19 and characterized
symptomatic COVID-19 infections after the vaccine in belatacept-treated KTRs. Among the …
in kidney transplant recipients (KTRs) treated with belatacept. We analyzed the humoral
response in belatacept-treated KTRs without a history of SARS-CoV-2 infection who
received three injections of BNT162b2-mRNA COVID-19 vaccine. We also investigated
vaccine immunogenicity in belatacept-treated KTRs with prior COVID-19 and characterized
symptomatic COVID-19 infections after the vaccine in belatacept-treated KTRs. Among the …